Consolidated Statements Of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
|
| Income Statement [Abstract] | ||||
| Revenues | $ 3,930,868 | $ 747,612 | $ 5,678,997 | $ 1,874,163 |
| Cost of goods sold | 2,730,286 | 623,761 | 4,303,750 | 1,668,192 |
| Gross Margin | 1,200,582 | 123,851 | 1,375,247 | 205,971 |
| Operating Expenses | ||||
| Operations | 440,445 | 1,581,818 | 1,148,348 | 2,468,121 |
| Research and development | 1,987,890 | 1,266,956 | 3,126,017 | 1,716,920 |
| Sales and marketing | 675,490 | 563,756 | 1,662,398 | 970,709 |
| General and administrative | 1,460,073 | 1,815,314 | 2,903,229 | 2,877,718 |
| Stock based compensation | 1,196,325 | 1,246,796 | 2,107,931 | 2,002,267 |
| Total operating expenses | 5,760,223 | 6,474,640 | 10,947,923 | 10,035,735 |
| Operating loss | (4,559,641) | (6,350,789) | (9,572,676) | (9,829,764) |
| Other (income) expense | ||||
| Change in fair value of derivative liability | (162,482) | (686,744) | (189,002) | (593,822) |
| Investment loss (income), net | 333,867 | (92,711) | 573,357 | (192,134) |
| Interest expense | 19,696 | 32,485 | 41,553 | 68,172 |
| Other, net | 331,095 | 227,163 | 651,008 | 311,204 |
| Net loss from continuing operations | (5,081,817) | (5,830,982) | (10,649,592) | (9,423,184) |
| Loss from discontinued operations | (599,511) | (413,495) | (842,084) | (632,892) |
| Net loss | $ (5,681,328) | $ (6,244,477) | $ (11,491,676) | $ (10,056,076) |
| Loss per share - basic and diluted | ||||
| Continuing operations | $ (0.09) | $ (0.11) | $ (0.19) | $ (0.18) |
| Discontinued operations | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.01) |
| Weighted average shares outstanding - basic and diluted | 55,606,336 | 54,078,111 | 55,270,838 | 53,928,133 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|